ArticleInternational journal of medical sciences2026
Risk Factors for Anti-Glaucoma Surgery in Posner-Schlossman Syndrome Patients: an 8-Year Retrospective Study.
Article in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study identifies older age, higher attack frequency and RNFL defect as risks for anti-glaucoma surgery in 106 Chinese Posner-Schlossman Syndrome (PSS) patients via an 8-year retrospective study. Purpose: To investigate the risk factors for anti-glaucoma surgery in Chinese patients with PSS. Patients and Methods: Retrospective study Results: Among 106 patients, 62 cases were in the low-frequency group and 44 were in the high-frequency group. Patients in high-frequency group had a longer duration of attacks, more iris atrophy, and systemic administration of ganciclovir (p = 0.044, 0.044, 0.012, respectively). They also had a higher tendency to develop secondary glaucoma and more probability of undergoing anti-glaucoma surgery (p = 0.014, 0.017 respectively). 18 cases (17%) received anti-glaucoma surgery while binary logistic regression showed that the risk factors for receiving anti-glaucoma surgery were elder age of onset (odds ratio (OR) = 1.080; 95% confidence interval (CI): 1.012-1.153; p = 0.021), higher frequency of attacks (OR = 6.186; 95% CI: 1.276, 29.976; p = 0.024), and RNFL defect (OR = 4.804; 95% CI: 1.040, 22.184; p = 0.044). Conclusion: Risk factors for anti-glaucoma surgery in patients with PSS were elder age of onset, higher frequency of attacks and RNFL defect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.